Telemedicine for Follow-Up of Rare Neurological Disease.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 30651041.
- Also identified by DOI 10.1161/STROKEAHA.118.023779.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Background and Purpose- Providing ongoing care for rare neurological conditions is challenging. Telemedicine can reduce patient travel. We set up and evaluated a telemedicine service for patients with a genetic form of stroke and dementia cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Methods- One hundred fourteen patients with mutation-positive cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (64 telemedicine and 50 face-to-face) were recruited. Patient and clinician satisfaction questionnaires rated the service to create a mean satisfaction score for both face-to-face and telemedicine follow-up appointments. Results- There was no difference in mean (SD) patient or clinician satisfaction scores between telemedicine and face-to-face appointments (patient: 4.57 [0.56] and 4.69 [0.42]; P=0.99; clinician: 4.55 [0.49] and 4.60 [0.43]; P=0.44). Conclusions- Telemedicine follow-up was suited to patients with stroke and dementia and offered satisfaction levels similar to that for face-to-face consultations.
Medical subject headings
- CADASIL
- Nervous System Diseases
- Rare Diseases
- Telemedicine